The expression and function of the GH receptor is critical for the actions of pituitary GH in the intact animal. The role of systemic factors in the reduced expression of the GH receptor and consequent GH insensitivity in pathological states such as sepsis, malnutrition, and poorly controlled diabetes mellitus is unclear. In the current study, we demonstrate that saturated (palmitic and myristic; 50 M) fatty acids ( P ITUITARY GH is essential for postnatal linear growth and regulation of metabolism of fat, carbohydrate, and protein in animals. At the tissue level, these pleiotropic actions of GH result from the interaction of GH with the GH receptor and expression and function of the GH receptor is critical for the action of GH (1). Dysregulation of the GH/GH receptor axis has been implicated in some forms of short stature, the pathogenesis of certain types of tumors, in the initiation and progression of chronic complications of diabetes mellitus (DM) such as nephropathy and retinopathy, and in determining morbidity associated with catabolic states such as malnutrition, trauma, sepsis, or surgery. A feature that is common to the GH receptor transcripts from different species is the heterogeneity in the 5Ј-untranslated region (UTR) (2). This heterogeneity in the 5Ј-UTR results from splicing of the various exon 1 fragments to a common splice site located 11 bp upstream of the initiating ATG. Although the number of 5Ј-untranslated exons varies among species, in all examples the location of the splice site from the initiating ATG is constant. Disparate 5Ј-untranslated exons are under the control of individual promoters. In the mouse, three 5Ј-UTRs (termed L1, L2, and L5) have been identified and their regulatory elements characterized in some detail (3-9). The L2 transcript is the dominant transcript expressed in postnatal life, constituting 50-80% of the hepatic GHR transcripts in the nonpregnant adult animal (2, 7).
P ITUITARY GH is essential for postnatal linear growth and regulation of metabolism of fat, carbohydrate, and protein in animals. At the tissue level, these pleiotropic actions of GH result from the interaction of GH with the GH receptor and expression and function of the GH receptor is critical for the action of GH (1) . Dysregulation of the GH/GH receptor axis has been implicated in some forms of short stature, the pathogenesis of certain types of tumors, in the initiation and progression of chronic complications of diabetes mellitus (DM) such as nephropathy and retinopathy, and in determining morbidity associated with catabolic states such as malnutrition, trauma, sepsis, or surgery. A feature that is common to the GH receptor transcripts from different species is the heterogeneity in the 5Ј-untranslated region (UTR) (2) . This heterogeneity in the 5Ј-UTR results from splicing of the various exon 1 fragments to a common splice site located 11 bp upstream of the initiating ATG. Although the number of 5Ј-untranslated exons varies among species, in all examples the location of the splice site from the initiating ATG is constant. Disparate 5Ј-untranslated exons are under the control of individual promoters. In the mouse, three 5Ј-UTRs (termed L1, L2, and L5) have been identified and their regulatory elements characterized in some detail (3) (4) (5) (6) (7) (8) (9) . The L2 transcript is the dominant transcript expressed in postnatal life, constituting 50-80% of the hepatic GHR transcripts in the nonpregnant adult animal (2, 7) .
The GH/GH receptor axis plays a critical permissive role in the pathogenesis of diabetic nephropathy and retinopathy (10) . Poorly controlled DM is a state of GH insensitivity associated with decreased expression of hepatic GH receptor (8, (11) (12) (13) . Whereas previous studies have elucidated aspects of the molecular basis for modulation of GH receptor gene expression in DM (9, 14) , the systemic/circulatory factors that play a role in the reduced expression of the GH receptor in DM and consequent GH insensitivity are as yet unknown. Similarly, the pathogenesis of acquired GH insensitivity in children born small for gestational age (SGA) or very low birth children (VLBW) remains unclear (15) . The present study was undertaken to identify and characterize the molecular basis for the regulatory control of the GH receptor gene by metabolic signals. Our results reveal that fatty acids (FA) directly inhibit expression of the GH receptor gene. Our studies also support a role for the Krü ppel-type zinc finger transcription factor, ZBP-89, in this action of FA on GH receptor expression.
RESULTS

Saturated But Not Unsaturated Fatty Acids Modulate Activity of the Promoter of the L2 Transcript
Acquired states of GH insensitivity such as poorly controlled DM and SGA are associated with decreased expression of the GH receptor. These pathological states are also characterized by dysregulation of FA metabolism (16) . To identify the metabolic/hormonal signals that transduce the effect of DM on the GH receptor gene, we investigated the effect of FA on promoter activity of the dominant GH receptor transcript, the L2 transcript. Exposure of the L2 promoterluciferase stable cell line to palmitic acid (50 M), the major saturated FA in plasma, for 24 h resulted in an approximately 50% decrease in luciferase activity (Fig.  1A ). Experiments measuring cell viability verified that this abrogation of activity of the L2 promoter was not secondary to increase in cell death (data not shown). Myristic acid (50 M) also resulted in a similar decrease in L2 promoter activity. In contrast, other saturated FAs such as stearic (200 M) and arachidic acid (200 M), and unsaturated FAs such as oleic (200 M) and linoleic (200 M), did not alter the activity of the L2 promoter (Fig. 1A) . The effects of saturated FAs could either be due to a direct action or due to products generated by its metabolism. Thus, palmitate has been linked to the activation of several signaling pathways, e.g. by its metabolism to diacylyglycerol and subsequent activation of protein kinase C (17, 18) , by palmitoylation of proteins (19) , or via synthesis of ceramide (20, 21) . All of these events require conversion of palmitate to palmitoyl-coenzyme A (CoA) by acylCoA synthetase. To distinguish between direct and indirect effects of FA, we tested the effects of a nonmetabolizable analog of palmitic acid, 2-bromoplamitate, on L2 promoter activity. These experiments established that the bromopalmitate analog mimicked the effects of palmitic acid on L2 promoter activity suggesting that the effect of palmitate was not dependent on the metabolism of palmitate (Fig. 1B) . Furthermore, triacsin C, an inhibitor of the enzyme acyl-CoA synthetase, failed to abrogate the effect of palmitic acid on the L2 promoter (Fig. 1B) . Hence, these results support the conclusion that the effects of palmitic acid on L2 promoter activity are not dependent on the intracellular metabolism of palmitate.
To verify the biological significance of the observed effect of palmitic acid on the GH receptor promoter, we investigated the effect of FAs on the expression of endogenous GH receptor in 3T3-L1 preadipocytes. 3T3-L1 cells are an established model system for the study of GH receptor expression and function. 3T3-L1 preadipocytes were exposed for 24 h to either vehicle (BSA) or FAs at the indicated concentrations, and the abundance of endogenous GH receptor mRNA and protein in these cells quantitated by real-time RT-PCR and Western blot assays, respectively. These results demonstrate that exposure of the cells to palmitic acid (50-400 M) decreased the steady state levels of the major GH receptor transcript, L2, by 50-60% (Fig. 1C) . In concordance with the effects observed on the L2 promoter (Fig. 1A) , the inhibition of GH receptor mRNA by FA was specific to palmitic acid and was not observed with similar concentrations of the unsaturated FA, linoleic acid (Fig. 1C) . Western blot analysis revealed that the abundance of GH receptor protein, but not that of a control protein actin, was also decreased in 3T3-L1 cells exposed to palmitic acid (Fig. 1D ).
Identification and Characterization of a FAResponse Element in the GH Receptor Promoter
To investigate the molecular basis for the observed effect of FA on GH receptor gene expression, we used conventional deletional analysis in transient transfection experiments to localize the effect of FA to a region (Х 200 bp) of the L2 promoter (Fig. 2, A and B) . This 200-bp segment was analyzed by EMSA for protein binding activity using three overlapping oligonucleotides (D1, D2, and D3) that spanned this region of the L2 promoter (Fig. 2B) . Exploiting this strategy, we identified a 61-bp region (we term L2-D1) of the distal L2 GH receptor promoter, located 647-587 bp 5Ј to the transcription start site that displayed protein-binding activity; D2 and D3 did not exhibit protein-binding activity (data not shown). Addition of nuclear extract from female mouse liver to an aliquot of 32 P-labeled L2-D1 resulted in the formation of a protein-DNA complex (complex A, Fig. 3A) . The sequence specificity of this protein-DNA complex was established by demonstrating that, whereas a 10-fold molar excess of unlabeled L2-D1 eliminated the formation of protein-DNA complex A, an oligonucleotide with an unrelated sequence [random sequence (RS)] did not affect the binding even at a 40-fold molar excess (Fig. 3A) . Analysis of the nucleotide sequence of this region using MatInspector (22) and TFSearch (23) algorithms revealed the presence of putative binding sites for a restricted (10-12) number of DNA-binding proteins.
Using EMSA with liver nuclear extracts, we systematically screened for factor(s) interacting with L2-D1 element and narrowed the identity of the candidate protein(s) to ZBP-89/BERF-1/BFCOL1, a Krü ppel-like zinc finger transcription factor that binds to a GC-rich sequence motif in a sequence-specific manner (24) . To confirm the identity of the proteins(s) participating in the formation of protein-DNA complex A, we performed competition experiments with oligonucleotides containing consensus binding sites for ZBP-89 (25) and related Krü ppel-family protein Sp1 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) respectively. Although the addition of molar excess of ZBP oligonucleotide abrogated the formation of protein-complex A, addition of the Sp1 oligonucleotide did not alter the formation of this complex (Fig. 3B ). The addition of antibody specific for ZBP-89 in an EMSA reaction with 32 P-labeled L2-D1 and mouse liver nuclear extracts retarded the mobility of complex A and the appearance of a supershifted (SS) complex (Fig. 3C) . In parallel experiments, addition of antibodies specific for Sp1, Sp2, and Sp3 did not result in alteration of the mobility of complex A (data not shown). These results indicate the presence of ZBP-89 in the protein-DNA complex formed with mouse liver nuclear proteins and the L2-D1 sequence. Luciferase activity normalized for protein content (mean Ϯ SE; n ϭ 8-10) is depicted relative to activity with exposure to BSA alone (diagonally hatched bar). *, P Ͻ 0.01 compared with BSA alone. B, Inhibition of GH receptor promoter activity by palmitic does not require metabolism of palmitic acid. BNL CL.2 (mouse liver) cells stably expressing the full-length (2 kb) L2 promoter-luciferase fusion gene were exposed for 24 h to either 50 M BSA-conjugated palmitic or 50 M bromo-palmitic acid, and luciferase activity measured (open bars; n ϭ 3-5). In another set of experiments (solid bars; n ϭ 3-5), BNL CL.2 cells stably expressing the full-length (2 kb) L2 promoter-luciferase fusion gene were exposed to 1 M triacsin C in the presence or absence of 50 M BSA-conjugated palmitic acid. Luciferase activity (mean Ϯ SE; normalized for protein content) is depicted relative to activity with exposure to BSA alone (diagonally hatched bar). * and #, P Ͻ 0.01 compared with BSA or triacsin C, respectively. C, Saturated FAs inhibit expression of endogenous GH receptor mRNA. 3T3-L1 preadipocytes were exposed for 24 h in serum-free conditions to the indicated concentrations of palmitic acid (open bars) or linoleic acid (solid bars) or vehicle (BSA; diagonally hatched bar), followed by harvesting of the cells for extraction of RNA. The abundance of the L2 mRNA transcript of the GH receptor was measured by real-time RT-PCR using methods previously described (8) . The results (mean Ϯ SE; n ϭ 3-4) are depicted relative to mRNA abundance with exposure to BSA alone (diagonally hatched bar). *, P Ͻ 0.01 compared with BSA alone. D, Palmitic acid inhibits expression of endogenous GH receptor. 3T3-L1 preadipocytes were exposed for 24 h in serum-free conditions to BSA (lane A) or the indicated concentrations of palmitic acid (lanes B and C) and whole cell lysates prepared. Aliquots of equal amounts of protein were size-fractionated by electrophoresis, transferred on to nitrocellulose membrane by Western blotting, and the membrane sequentially probed with antibodies specific for the GH receptor (AL-47) or actin. The specific signal was detected using the chemiluminescence system as described in Materials and Methods. The positions of the molecular weight marker, the GH receptor, and actin are indicated. Results depicted are representative of two such experiments.
The in vivo interaction of ZBP-89 with the L2-D1 sequence was verified by the chromatin immunoprecipitation (ChIP) assay. For this purpose 3T3-L1 cells, naive or infected with an adenovirus directing the expression of ZBP-89, were used in ChIP assays to demonstrate in vivo occupancy of the L2-D1 site by ZBP-89 (Fig. 3D) . The specificity of the ChIP assay was verified by demonstrating absence of interaction of ZBP-89 with the L1 GH receptor promoter (Fig. 3D, inset) .
ZBP-89 is a bifunctional transcription factor displaying a transcription activation domain at C terminus and a repressor domain at N terminus (26) . To investigate the functional significance of ZBP-89 binding to the L2-D1 element, we engineered a L2 promoter-luciferase construct (pGL3B-L2[2kb⌬D1]) with deletion of the ZBP-89 binding site and tested its activity in transient transfection assays in BNL CL.2 cells. Whereas loss of the L2-D1 site did not alter basal L2 promoter activity (Fig. 4A) , absence of the ZBP-89 binding site L2-D1 resulted in abrogation of the palmitic acid's effect on the L2 promoter (Fig. 4B) . Possible explanations for this lack of effect on basal promoter activity could be low levels of expression of endogenous ZBP-89 in BNL CL.2 cells or the presence of additional ZBP-89 sites within the L2 promoter (vide infra). We further investigated the functional role of ZBP-89 in controlling GH receptor gene expression by overexpressing ZBP-89 in BNL CL.2 cells. These results demonstrate that ectopic expression of ZBP-89 significantly augments the activity of the L2 promoter (Fig. 4C ). The specificity of this effect was verified by demonstrating that deletion of ZBP-89 binding site (pGL3B-L2[2kb⌬D1] resulted in abrogation of this effect of ZBP-89 on the L2 promoter (Fig. 4C ). To further confirm this effect of ZBP-89 on L2 promoter activity, we tested this effect in Schneider's Drosophila Line 2 (SL2) cells. SL2 cells have been shown to be devoid of many of the Krü ppel-like factors and hence use of this model system decreases the possibility of overlapping and potentially confounding effects from other members of the Krü ppel-like family. These data indicate that, similar to the results obtained in BNL CL.2 cells, ZBP-89 increased the activity of the L2 promoter ( Fig.  4C ; inset). . One day after transfection, the cells were exposed for 24 h to either vehicle (BSA) or BSA-conjugated palmitic acid and the luciferase activity measured. Cotransfection of Renilla luciferase was used to normalize transfection efficiency. The normalized luciferase activity (mean Ϯ SE; n ϭ 5-7) for each individual construct exposed to palmitic acid (shaded bars) is depicted as relative to activity of the respective construct exposed to BSA alone (open bar), designated as 100%. *, P Ͻ 0.01 compared with BSA alone. B, Schematic representation of the location and nucleotide sequence of the L2-D1 FA-response element. The relative locations of the Х 200-bp region (stippled box) of the L2 promoter identified to encompass a putative FA-response element and the three overlapping oligonucleotide probes (D1, D2, and D3) used in EMSA to screen for protein-binding activity of this region are indicated. The distance from the transcription start site of the 200-bp region and the D1 probe is indicated. The nucleotide sequence of the D1 probe is specified.
ZBP-89 Augments FA Effects on the L2 Promoter
Our results established that the ZBP-89 binding site overlapped with the putative FA-response element. To ascertain the role of ZBP-89 in the effect of FA on GH receptor gene expression, we tested the effect of ZBP-89 overexpression on FA-induced inhibition of L2 promoter activity. These results indicate that in BNL CL.2 cells, ectopic expression of ZBP-89 amplifies the inhibitory effect of FA on L2 promoter activity (Fig. 4D ).
The specificity of this effect was verified by demonstrating that the deletion of the L2-D1 ZBP-binding site resulted in abrogation of the FA-sensitizing effect of ZBP-89 (Fig. 4D ).
Identification of a Second (Proximal) ZBP-89 Binding Site in the L2 Promoter
Our aforementioned studies with the native L2 promoter suggested the possibility of additional ZBP-89 sites within the L2 promoter. Upon verifying the role of the L2-D1 element in ZBP-mediated FA effect on the L2 promoter, we conducted a systematic survey of the L2 promoter for evidence of other ZBP-89 binding sites by testing L2-promoter deletion constructs for the FA-sensitizing effect of ZBP-89. These results established that L2-promoter constructs with progressively restricted lengths (0.7, 0.344, and 0.075 kb) of the L2 promoter retained the FA-sensitizing effect of ZBP-89 (Fig. 5A) . In contrast, the shortest fragment (0.043 kb) did not display such an effect (Fig. 5A) , suggesting the presence of additional ZBP-89 binding site(s) between Ϫ75 and Ϫ43 bp of the L2 promoter. Bioinformatic analysis of the primary sequence of this region using the MatInspector (22) and TFSearch (23) algorithms revealed a putative ZBP-89 binding site (we termed L2-A2) located 36-79 bp 5Ј to the transcription start site (Fig. 5B) . Addition of nuclear extract from female mouse liver to an aliquot of 32 P-labeled L2-A2 resulted in the formation of two protein-DNA complexes (complexes A and B; Fig. 5C ). To confirm the identity of the proteins(s) participating in the formation of the protein-DNA complexes, we performed competition experiments with oligonucleotides containing consensus binding sites for ZBP-89 and related Krü ppel-family protein Sp1, respectively. Whereas the addition of molar excess of ZBP oligonucleotide abrogated the formation of protein-complexes A and B, addition of the Sp1 oligonucleotide failed to abrogate the formation of these complexes (Fig. 5C) . The addition of antibody specific for ZBP-89 in an EMSA reaction with 32 P-labeled L2-A2 and mouse liver nuclear extracts resulted in the appearance of SS with attenuation of complexes A and B (Fig. 5D) . In parallel experiments addition of antibodies specific for Sp1, Sp2, and Sp3 did not result in alteration of the mobility of complex A and B (data not shown). We next used the ChIP assay to confirm the in vivo occupancy of the L2-A2 site by ZBP-89 in 3T3-L1 preadipocytes (Fig.  5E ). These results support the conclusion that ZBP-89 participates in the formation of the DNA-protein complexes at the L2-A2 site.
To investigate the functional significance of the L2-A2 ZBP-89 binding site, promoter-reporter constructs were engineered with deletion of the L2-A2 ZBP-89 binding site either in isolation (pGL3B-L2[2kb⌬A2]) or in combination with deletion of the D1 ZBP-89 binding site (pGL3B-L2[2kb⌬D1/A2]). Transient transfection of these constructs into BNL CL.2 cells revealed that absence of the L2-A2 site, either in isolation or in combination with the L2-D1 site, resulted in significant abrogation of the basal activity of the L2 promoter (Fig. 6A) . Furthermore, in the absence of the L2-A2 site, palmitic acid was devoid of effect on the L2 promoter (Fig. 6B) . In contrast, the effect of ectopic expression of ZBP-89 on the L2 promoter was retained in the absence of the L2-A2 site (Fig. 6C) . However, the ability of ZBP-89 to amplify the inhibitory actions of palmitic acid on L2 promoter activity required the presence of the L2-A2 site (Fig. 6D) . These results suggest a model wherein the two ZBP-89 binding sites, L2-D1 and L2-A2, are essential for palmitic acid's inhibitory effect on the L2 promoter. Similarly, the two sites are not individually sufficient for the enhancing effect of ZBP-89 on palmitic acid-induced inhibition of L2 promoter activity with both the sites being essential for this effect, thereby implying cooperativity between these two ZBP-89 binding sites.
ZBP-89 Augments FA Effects on Endogenous GH Receptor Gene Expression
To verify the biological relevance of the results obtained with in vitro promoter studies, we investigated the effect of ectopic expression of ZBP-89 on PAinduced inhibition of endogenous GH receptor gene expression. 3T3-L1 preadipocytes were infected with ZBP-89 overexpressing adenovirus and after exposure of the cells to PA, the steady state abundance of the L2 transcript was quantitated by real-time RT-PCR. These results established that consistent with the results obtained with the GH receptor promoterluciferase construct, overexpression of ZBP-89 increased the steady state levels of endogenous GH receptor mRNA (Fig. 7A ) and the PA-induced decrement in L2 mRNA levels was significantly greater in cells expressing the ZBP-89 adenovirus as compared with cells infected with a control (␤-galactosidase expressing) adenovirus (Fig. 7B) .
DISCUSSION
The main findings of this study are that saturated FAs directly inhibit GH receptor gene expression, this effect is mediated by direct action of FA and not secondary to metabolites generated by intracellular metabolism of FA, and that the Krü ppel-type zinc finger transcription factor ZBP-89 plays a role in this action of FA on GH receptor gene expression.
Studies conducted during the past few years have highlighted the importance of FAs in the regulation of gene expression including those genes related to nutrition and growth (27) . To the best of our knowledge, the current study is the first to demonstrate that FAs alter the expression of the GH receptor gene. Our studies indicate that saturated, but not unsaturated, FAs inhibit expression of the GH receptor gene. Furthermore, our results demonstrating comparable effects with palmitic acid and a nonmetabolizable analog of palmitic acid (bromo-palmitic acid), and the failure of inhibition of palmitic acid metabolism to abrogate palmitic acid's effects on GH receptor expression, support the conclusion that this effect of palmitic acid is due to direct actions of palmitic acid. FAmediated inhibition of GH receptor promoter activity and expression occurred at a relatively low concentration of FA (50-200 M FA) and thus was unlikely to be secondary to a nonspecific detergent-like effect. Furthermore, similar concentrations of palmitic acid failed to alter the activity of either the pGL3-Basic vector or that of an unrelated promoter (c-fos promoter enhancer) ( Fig. 2A) , supporting the specificity of the observed effect of palmitic acid on the L2-GHR promoter. There are multiple ways in which FA can directly interact with the cell. One of the mechanisms postulated for the biological effects of FA is via their ability to act as ligands for PPAR. The lack of effect (data not shown) of fenofibrate (500 M) and rosiglitazone (10 M), ligands for PPAR␣ and PPAR␥ respectively, on GH receptor L2 promoter activity argues against a role for PPAR in the observed effect of FA on GH receptor expression. Similarly, the effect of FA is unlikely to be solely mediated by the newly discovered family of G protein-coupled receptors for FA (e.g. GPR40 family and GPR120) because the profile of fatty acid ligands for these receptors is at variance with that observed for the effect of FA on GH receptor. Whereas the observed effects of FA on GH receptor gene expression are restricted to medium-chain saturated FAs, GPR40 is activated by medium and long chain saturated and unsaturated FAs (28, 29), GPR41 and GPR43 by short chain carboxylic acids (30-32), (L2[2kb⌬D1] ). One day after transfection, the cells were exposed for 24 h to either vehicle (BSA) or BSA-conjugated palmitic acid (50 M) and the luciferase activity measured (luciferase values ranged from 8-62 RLU). Cotransfection of Renilla luciferase was used to normalize transfection efficiency. The normalized luciferase activity (mean Ϯ SE; n ϭ 3-5) for each individual construct exposed to palmitic acid in the absence or presence of ectopically expressed ZBP-89 is depicted as relative to activity of the respective construct exposed to BSA alone (diagonally hatched bar), designated as 100%. *, P Ͻ 0.01 compared with absence of ectopically expressed ZBP-89 (open bars). and GPR120 by long chain saturated and unsaturated FAs (33) . It is noteworthy that previous studies (34) have established that saturated FA can interact with Toll-family of receptors (e.g. TLR2 and TLR4) to induce nuclear factor-B expression and this effect was observed at molar concentrations (75 M) similar to that observed in the current studies. We have obtained preliminary data (data not shown) to suggest that the effect of saturated FA on GH receptor is mediated via the Toll-family of receptors.
ZBP-89 (BFCOLI1, BERF-1, ZNF148, Zfp148) is a ubiquitously expressed Krü ppel-type zinc finger protein with pleiotropic actions including regulation of transcription, cell growth arrest, and cell death (24) . A recent study demonstrated that ZBP-89 acts as a transcriptional activator of the bovine GH receptor gene (35) . Our results confirm that ZBP-89 increases GH receptor promoter activity. Furthermore, our studies extend this observation by establishing that ZBP-89 plays a role in FAs effect on the GH receptor gene and that these actions of ZBP-89 on the GH receptor promoter are mediated by two ZBP-binding sites approximately 600 bp apart. Cooperativity between these two ZBP-89 binding sites is evident by the finding that the integrity of these two sites is essential for the effect of ZBP-89 effect of enhancing palmitic acid's inhibition of GH receptor promoter activity. The exact mechanism by which ZBP-89 enhances the effect of FA on the GH receptor promoter is not clear at this time. Our studies indicate that the binding of ZBP-89 to the GH receptor element is not altered by FA (data not shown). However, the possibility that posttranslational modifications of ZBP-89 play a role in the action of ZBP-89 cannot be excluded. Overlapping of the ZBP-89-binding site and the FA-response element in the L2 promoter raises the possibility that ZBP-89 is solely responsible for transducing the effects of FA on GH receptor gene expression. However, the finding that ectopic expression of ZBP-89 increases, whereas FA inhibits, L2 promoter activity suggests a role for either posttranslational modifications of ZBP-89 by FA or for other proteins interacting with ZBP-89. It is noteworthy that ZBP-89 has been shown to interact with other proteins, such as SP1 (36) , signal transducers and activators of transcription 3 (37), p53 (38) , and polymerase I and transcript-release factor (39) .
The GH/GH receptor axis plays a critical role in statural growth and regulation of metabolism. The findings of the current study impact on our understanding of the pathophysiology of three disease states; short stature, type 1 DM, and obesity-linked type 2 DM. Children who are born SGA including those born with extreme reductions in birth weight, VLBW, are exposed to abnormalities in circulating lipid concentrations both in the short-term as a consequence of artificial nutritional support regimens including total parenteral nutrition, and in the long-term due to persistent lipid abnormalities in postnatal life (40, 41) . Approximately 15-20% of SGA and VLBW children fail . Forty-eight hours after infection, the cells were harvested for extraction of RNA. The abundance of the L2 mRNA transcript of the GH receptor was measured by real-time RT-PCR using methods previously described (8) . The results (mean Ϯ SE; n ϭ 2) are depicted relative to mRNA abundance with infection with ␤-galactosidase expressing adenovirus. Inset, Western blot analysis demonstrating adenovirally mediated expression of ZBP-89 in 3T3-L1 preadipocytes. Whole cell lysates of 3T3-L1 preadipocytes either naïve (C) or infected with 100 or 300 multiplicity of infection of recombinant Ad-ZBP-89 adenovirus expressing myc-flag-tagged ZBP-89 were size-fractionated by electrophoresis, transferred on to nitrocellulose membrane by Western blotting, and the membrane probed with anti-myc antibody. The specific signal was detected using the chemiluminescence system as described in Materials and Methods. The positions of the molecular weight marker, the ZBP-89 protein, and a nonspecific (NS) band are indicated. B, ZBP-89 augments FA effects on endogenous GH receptor gene expression. 3T3-L1 preadipocytes were infected with recombinant adenovirus expressing either ␤-galactosidase or ZBP-89. Forty-eight hours after infection, the cells were transferred to serum-free conditions and then exposed to palmitic acid (200 M; solid bars) or vehicle (BSA; open bar) for 24 h, followed by harvesting of the cells for extraction of RNA. The abundance of the L2 mRNA transcript of the GH receptor was measured by real-time RT-PCR using methods previously described (8) . The results (mean Ϯ SE; n ϭ 3) are depicted relative to mRNA abundance with exposure to BSA alone (open bar). ‫,ء‬ P Ͻ 0.01 compared with ␤-galactosidase infected cells.
to exhibit catch-up growth with detrimental effects on their final adult height (42) . Abnormalities in the GH/GH receptor axis are implicated in the pathogenesis of growth retardation in SGA and VLBW children (15, 43) . Results from the present study indicating effects of FA on GHR expression provide a molecular basis for the state of GH insensitivity observed in these cohorts. Resistance to actions of GH due to down-regulation of the GH receptor is also a hallmark of poorly controlled type 1 DM. Whereas many of the molecular mechanisms that play a role in regulation of the GH/GH receptor axis in DM have been elucidated (9) , the metabolic signals that transduce these changes have not been identified. Results from the present study suggest that alterations in the concentration of circulating levels of FA could play a role in the decrease in expression of GH receptor in poorly controlled type 1 DM. Failure of pancreatic ␤-cell mass to compensate for insulin resistance is a critical event in the pathogenesis of type II diabetes. GH receptors are expressed on pancreatic ␤ cells and the GH/IGF-I axis is believed to play a stimulatory role in ␤ cell mitogenesis and growth (44) . Results from the current study suggest that FA-induced down-regulation of GH receptors on pancreatic ␤ cells could contribute to the failure of ␤ cell mass to compensate for insulin resistance in obesity-linked type 2 DM.
In summary, the current report establishes a role for saturated FAs in the regulation of expression of the GH receptor gene. Our studies have identified cis elements in the GH receptor promoter that play a role in the FA-induced inhibition of GH receptor expression. We have elucidated a role for the Krü ppel-like zinc finger binding protein ZBP-89 in the molecular mechanism underlying this phenomenon. Our studies suggest a molecular basis for the alterations in GH receptor expression in DM and SGA.
MATERIALS AND METHODS
Oligonucleotides
The following synthetic oligonucleotides were used in these experiments:
L2 
Fatty Acid Solution Preparations
Stock FA solutions were prepared by conjugating FA with fatty acid-free BSA (Sigma, St. Louis, MO) as previously described (45) . In brief, sufficient FAs were dissolved in preheated 0.1 N NaOH and diluted 1:10 in prewarmed (45-50 C) DMEM containing 12% (wt/vol) BSA, to give a final FA concentration of 2.0 mM. This gave a final molar ratio of FA/BSA of 1.5:1.0, and predicted to give an unbound FA concentration of Х 8 nM (46) (47) (48) . Stock FA solutions were filter sterilized and diluted with cell culture media for use in experiments. Control media contained 0.1 N NaOH and BSA but was devoid of lipid. Where required, the pH of preparations was adjusted to 7.4.
Reporter Gene Constructs
Luciferase reporter gene constructs were engineered to contain various portions of the GH receptor 5Ј-flanking region. ] were engineered by using PCR; the 5Ј-end of these constructs was defined by the oligonucleotides L2-F7, L2-F8, L2-F9, L2F4, and L2F5, respectively. pGL3B-L2[2kb⌬D1] and pGL3B-L2[2kb⌬A2] were created by deletion of the L2-D1 and L2-A2 binding sites respectively from pGL3B-L2[-2.0] using QuikChange (Stratagene, La Jolla, CA); the double mutant pGL3B-L2[2kb⌬D1/A2] was created using a similar strategy. All constructs were sequenced through the vector-insert junctions to ensure nucleotide fidelity and verify directionality. The reporter plasmid fos-Luc containing the mouse c-fos enhancer (Ϫ379 to ϩ1) upstream of the luciferase gene (49) was provided by J. Schwartz.
Cell Culture
The culture media used for cell culture experiments were obtained from Invitrogen (Carlsbad, CA) unless otherwise stated. BNL CL.2 cells [mouse embryonic liver, hepatocytelike cells; American Type Culture Collection (Manassas, VA): TIB-73] were maintained at 37 C in Eagle's DMEM (with nonessential amino acids, sodium pyruvate, and Earle's balanced salt solution), 10% fetal serum, with penicillin G (100 U/ml) and streptomycin (100 g/ml) in an atmosphere of 5% CO 2 /95% air. BNL CL.2 cells stably transfected with the L2[-2.0]-GH receptor promoter luciferase construct were maintained as described previously (50) . 3T3 preadipocytes were grown at 37 C in DMEM supplemented with 4.5 g/liter glucose, 10% calf serum, penicillin G (100 U/ml), and streptomycin (100 g/ml) in an atmosphere of 10% CO 2 /90% air.
Transient Expression of Reporter Gene
BNL CL.2 cells (0.20 ϫ 10 6 cells/35-mm plate) were plated 24 h before transfection. Three micrograms of plasmid DNA (comprising 1 g of reporter plasmid, 0.2 g of the internal Renilla luciferase control, and 1.8 g salmon sperm DNA) were transfected per plate using the LipofectAMINE method (Invitrogen). The following day, the cells were serum deprived for 10-12 h and then exposed in serum-free medium to either FAs or vehicle for 24 h and cells harvested for luciferase assay. For estimation of luciferase activity, the plates were rinsed twice with PBS and the cells harvested by the addition of 200 l lysis buffer (Dual Luciferase Assay System; Promega, Madison, WI). After a brief freeze-thaw cycle the insoluble debris was removed by centrifugation at 4 C for 2-3 min at 14,000 ϫ g. Twenty-microliter aliquots of the supernatant were then immediately processed for sequential quantitation of both firefly and Renilla luciferase activity (Dual Luciferase Assay System; Promega) using a Monolight TD 20/20 Luminometer (Turner Designs, Sunnyvale, CA). All transfections were performed in triplicates. Where indicated transfection efficiency was monitored by cotransfection of 0.2 g of the plasmid pRL-TK (Promega) expressing the Renilla luciferase. The results of the luciferase assay are expressed in relative light units equalized for transfection efficiency or protein concentration as indicated. Protein concentration of the supernatant was determined using the Bradford protein assay (Bio-Rad Laboratories, Hercules, CA). In certain experiments to achieve ectopic expression of ZBP-89, 0.2 g of plasmid expressing full-length Flag-tagged rat ZBP-89 cDNA (24) was also cotransfected.
Schneider's Drosophila Line 2 (SL2) cells were grown in 60-mm dishes in Schneider's medium (Invitrogen) supplemented with 10% fetal calf serum. The cells were allowed to grow to a confluency of 50-60% before commencement of transient transfection experiments. Eleven micrograms of plasmid DNA were transfected per plate using the calcium phosphate transfection method (Invitrogen). To investigate the role of ZBP-89 in regulating the activity of the GH receptor promoter, 4 g of the GH receptor promoter reporter plasmid (pGL3-L2) was cotransfected with and without 1 g of plasmid expressing ZBP. Plasmid RSV/␤-gal (1 g) was included in each transfection mixture to enable monitoring of transfection efficiency. The cells were exposed to the DNA precipitate for 48 h before being harvested and processed for chemiluminescent assays for measurement of luciferase (Promega) and ␤-galactosidase activity (CLONTECH, Palo Alto, CA).
EMSA
Nuclear extracts from mouse liver were prepared as previously described (7) . Protease inhibitors (leupeptin 2 g/ml, pepstatin 1 g/ml, and aprotinin 1%) were included in the buffers used to prepare the nuclear extracts. Doublestranded DNA fragments used as probes were obtained by annealing complementary custom synthesized single stranded oligonucleotides. The DNA was end-labeled with [␥ 32 P]ATP and T4 polynucleotide kinase. Approximately 14 fmol of DNA were added to 3 g of nuclear extract in a final volume of 50 l containing 1.5 g of poly(deoxyinosinedeoxycytosine), 20 mM Tris-HCl (pH 8.0), 50 mM NaCl, BSA (50 g/ml), 1% Nonidet P-40, 1 mM EDTA, 10% glycerol, and 1 mM dithiothreitol. After incubation at room temperature for 30 min, DNA-protein complexes were resolved by electrophoresis at room temperature through an 8% nondenaturing polyacrylamide gel [acrylamide, N,N-methylene-bisacrylamine (BIS) 80:1] with 90 mM Tris-borate (pH 8.5), 2 mM EDTA buffer. The gels were dried and subjected to autoradiography with intensifying screens (NEN Life Sciences, Boston, MA) at Ϫ80 C. Competition experiments included the addition of excess unlabeled DNA fragments to the reaction mix. In some experiments, nuclear extracts were incubated with the indicated amounts of polyclonal antibody against ZBP-89 (Ref. 25 or Santa Cruz Biotechnology, Inc.) for 30 min at room temperature before addition to the binding reactions.
Adenovirally Mediated Overexpression of ZBP-89
Replication-deficient recombinant Ad-ZBP-89 expressing full-length Flag-tagged rat ZBP-89 cDNA has been previously described (51) . The adenovirus was plaque purified, and a cesium chloride preparation was used for the experiments. Infection of 3T3-L1 preadipocytes was carried out at a multiplicity of infection of 100 pfu/cell in the presence of poly-Llysine hydrobromide (Sigma) as previously described (52) . Cells were harvested for analysis 48 h after infection.
Western Blot Analysis
Fifteen microgram aliquots of total cell lysate were heated for 5 min at 100 C in 62.5 mM Tris HCl, 10% (vol/vol) glycerol, 5% (vol/vol) 2-mercaptoethanol, 1.05% sodium dodecyl sulfate (SDS), and 0.004% bromophenol blue. The protein samples were then electrophoresed through a 4% stacking, 8% resolving, discontinuous SDS-polyacrylamide gel in 25 mM Tris HCl, 192 mM glycine, and 0.1% SDS buffer. BenchMark prestained protein ladder (Invitrogen) was also concurrently electrophoresed. After electrophoresis, the proteins were transferred to nitrocellulose membrane by electroblotting (Bio-Rad Laboratories) in transfer buffer [10 mM N-cyclohexyl-3-aminopropanesulfonic acid, 3 mM dithiothreitol, 15% methanol (pH 10.5)] for 1.5 h. The nitrocellulose membrane were then soaked overnight at 4 C in 5% nonfat dry milk, 1ϫ TBS, and 0.1% Tween 20 and subsequently probed with the AL-47 antibody (1:1000 dilution) against the GH receptor (courtesy of Stuart Frank, Internal Medicine, University of Alabama, Birmingham, AL) using the ECL enhanced chemiluminescence system (Amersham, Piscataway, NJ) according to the manufacturer's instructions.
ChIP
ChIP experiments were conducted on 3T3-L1 cells, either naive or ectopically expressing ZBP-89 via adenovirally mediated expression. These cells were subjected to ChIP using the EZ-ChIP kit (Upstate Biotechnology, Lake Placid, NY) with minor modifications. Briefly, 3T3-L1 preadipocytes were cross-linked by exposure to 1% formaldehyde in PBS for 10 min, followed by addition of 1 ml 10ϫ glycine to quench unreacted formaldehyde. The cells were then scraped in icecold PBS containing a protease inhibitor cocktail, centrifuged, and the cell pellet resuspended in SDS lysis buffer. The cell lysate was subjected to shearing to generate DNA fragments of Х 500 bp [7 ϫ 15 sec, at 4.5 output of an ultrasonic sonicator (Heat Systems-Ultrasonics)]. Samples were diluted 1:10 with ChIP dilution buffer [16.7 mM Tris-HCl (pH 8.0), 167 mM NaCl, 1.2 mM EDTA, 0.01% SDS, 1.1% Triton X-100, and protease inhibitor cocktail] and precleared with 10 g of salmon sperm DNA and 60 l packed Protein G-agarose beads/ml ChIP dilution buffer. For immunoprecipitation, samples containing 100 g of nuclear protein were incubated overnight at 4 C with the following antibodies individually: anti-ZBP (26), anti-acetyl H4 and RNA Pol 2 (Upstate Biotechnology). Normal rabbit and mouse IgG served as negative controls. After incubation of individual immunoprecipitate for 1 h with 10 g of salmon sperm DNA and 60 l of protein G agarose beads, the beads were washed, eluted, reverse cross-linked, and free DNA purified with a PCR purification kit. The L2-D1 (60 bp) and the L2A2 (100 bp) sites were amplified with 34-36 cycles of PCR (94 C for 20 sec, 60 C for 20 sec, and 72 C for 30 sec) using the respective primers. The promoter of the L1 transcript of the GH receptor (4) was used as a control with primers L1-F and L1-R amplifying a 182-bp region of the L1 promoter (38 cycles of PCR; 94 C for 30 sec, 52 C for 30 sec, and 72 C for 30 sec). Samples were separated on 2% agarose gels and stained with ethidium bromide.
Fluorescent 5-Nuclease RT-PCR
Total RNA was extracted using TRI-reagent (Molecular Research Center). Real-time quantitative reverse-transcription PCR (QT-PCR) using the ABI Prism 7000 sequence detection system (PE Applied Biosystems, Foster City, CA) was performed and analyzed following protocols described previously (8) .
Data Analysis
Data are presented as mean Ϯ SE unless otherwise indicated. The Mann-Whitney and Kruskal-Wallis nonparametric tests were performed to analyze statistical significance of the difference between the distribution of two and multiple independent samples, respectively. P values equal to or less than 0.05 were considered significant.
